CD8A and neoplasm: As before, CD8 T cells were essential for concomitant immunity, but interestingly concomitant immunity was not impacted by FTY720 treatment at the time of second tumor implantation (Fig. 7bi–iii), suggesting that recirculation is not necessary for distant tumor rejection after tumor-specific T cells are formed following primary tumor injection.